ReviewCancer drug resistance (Alhambra, Calif.)2023

Primary and acquired resistance to first-line therapy for clear cell renal cell carcinoma.

Serena Astore et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.